Original articleRacial differences in colorectal cancer mortality: The importance of stage and socioeconomic status
Introduction
Colorectal cancer is the second leading cause of death in the United States, accounting for more than 57,000 deaths in 1996 [1]. There are notable racial differences in both the incidence of and mortality from the disease [2]. According to recent data from the Surveillance, Epidemiology and End Results Program (SEER), the incidence rate is 13% higher for black males than for white males, and 27% higher among black females than among white females [3]. Despite a decreasing incidence and morbidity of colorectal cancer among whites since the 1980s, the rates for blacks have remained stable or even increased 2, 4.
Racial differences in mortality are even greater than those in incidence, with 27% and 38% higher age-adjusted death rates for black males and females compared with white males and females, respectively [5]. The higher mortality rate from colorectal cancer among black adults may be partially due to an advanced stage at diagnosis. A study of colorectal cancer in New York City revealed that although low socioeconomic status explained some of the excessive rates of late-stage diagnosis among blacks, black race remained an independent predictor of late-stage diagnosis [6]. The National Cancer Institute Black/White Cancer Survival Study (B/WCSS) [7] has detailed mortality differences between races for the period 1985 to 1986, prior to the widespread use of adjuvant chemotherapy. In our analysis, we present a more recent examination of racial differences in mortality when adjuvant chemotherapy was a much more common treatment modality [8].
We use survival models to estimate the effects of race and socioeconomic factors on colorectal cancer mortality for subjects from 1987 through 1993. We also investigate the extent to which stage at diagnosis affects the associations of race, gender, age, and socioeconomic factors with mortality, taking advantage of the large sample size to conduct stage-specific analyses without an appreciable loss of statistical power. We use data from the Pennsylvania State Tumor Registry and the 1990 U.S. Census of the Population to measure tumor-specific variables and socioeconomic factors.
Section snippets
Data
The data source for this study is the Expanded Cancer Incidence File from the Pennsylvania State Tumor Registry [9]. This file contains basic descriptors of tumor and demographic information for each diagnosed case, and is also linked to the state's death certificates to obtain the cause and date of death. The tumor registry is population based, and all Pennsylvania hospitals are required to report their incident cases to the registry. Additionally, there is a reciprocal agreement between
Results
Table 1 shows the distribution of cases by race and gender among the sociodemographic and tumor characteristics of each group. Age at diagnosis within each gender is greater for white than for black cases, with a mean difference of 2 years among males and 3 years among females (P < .0001). By every measure, black subjects were, on average, from communities with lower socioeconomic status than their white counterparts.
There are also racial differences in the stage at diagnosis and other tumor
Discussion
Analysis of data from a large population-based cancer registry in Pennsylvania reveals that black adults, especially men, have markedly higher fatality rates from colorectal cancer than do their white counterparts. Our findings reveal that racial discrepancies in mortality from colorectal cancer are due to both differences in the stage at presentation and in stage-specific mortality rates. We also show that the effect of socioeconomic status mediates some of this excess mortality. While earlier
Acknowledgements
Special thanks to Dona Schneider for supplying us with the census data and to Paul Speer and Mark Ontkush for the use of their programs enabling us to generate summary measures by minor civil division. Thanks to Gene Weinberg and the Pennsylvania Department of Health for making the Expanded Tumor Registry Data available for our analysis. Thanks to George Rhoads and Kitaw Demissee for their critical reading of the manuscript and to Susan Marcella for final editing assistance. Stephen Marcella
References (29)
- et al.
Births and deathsUnited States, 1996
(1997) - et al.
Colorectal cancer trends by race and anatomic subsites, 1975 to 1991
Arch Fam Med
(1995) - et al.
Health, United States, 1996–97 and injury chartbook
(1997) - et al.
Cancer incidence and mortality, 1973–1995a report care for the U.S
Cancer
(1998) - et al.
Atlas of United States mortality
(1996) - et al.
The late-stage diagnosis of colorectal cancerdemographic and socioeconomic factors
Am J Public Health.
(1996) - et al.
Determinants of black/white differences in colon cancer survival
J Natl Cancer Inst
(1995) - Vaughn DJ, Haller DG. The role of adjuvant chemotherapy in the treatment of colorectal cancer. Hematol Oncol Clin North...
Expanded cancer incidence file
(1997)- et al.
Colorectal cancers of rare histologic types compared with adenocarcinomas
Dis Colon Rectum
(1994)
Census ‘90 basics
Overcoming the absence of socioeconomic data in medical recordsvalidation and application of a census-based methodology
Am J Public Health
Survival analysis using the SAS systema practical guide
Cited by (150)
Inequities in colorectal and breast cancer screening: At the intersection of race/ethnicity, sexuality, and gender
2023, SSM - Population HealthAssociation of Liver Resection and Visiting More Than One Commission on Cancer Hospital for CRLM
2022, Journal of Surgical ResearchCitation Excerpt :For CRC broadly, in a retrospective cohort study using data from the national Surveillance, Epidemiology, and End Results Program, Black patients with CRC had a 32% higher risk of death than White patients after adjustment for co-variates.29 Factors associated with mortality differences include socioeconomic status, systemic discrimination, comorbidities, stage at diagnosis, and tumor biology.30-32 But access to appropriate therapy for this disease cannot be overlooked as a factor.
Healthcare Disparities and Colorectal Cancer
2022, Surgical Oncology Clinics of North AmericaThe interplay of pineal hormones and socioeconomic status leading to colorectal cancer disparity
2022, Translational OncologyRacial disparities in treatments and mortality among a large population-based cohort of older men and women with colorectal cancer
2022, Cancer Treatment and Research Communications